ANTARES PHARMA, INC. Business Finance Contracts & Agreements
31 Contracts & Agreements
- Credit Agreements (2 contracts)
- Exchange Agreements (1)
- Investor Rights Agreements (2)
- Loan Agreements (3)
- Purchase Agreements (2)
- Registration Rights Agreements (3)
- Release Agreements (1)
- Stock Agreements (9)
- Underwriting Agreements (3)
- Warrant Agreements (5)
- Asset Purchase Agreement, dated December 15, 2021, by and between Antares Pharma, Inc., Otter Pharmaceuticals, LLC, a subsidiary of Assertio Holdings, Inc., and Assertio Holdings,... (Filed With SEC on March 3, 2022)
- Credit Agreement, dated November 1, 2021, by and among Antares Pharma, Inc., Wells Fargo Bank, National Association, and the lenders from time to time party thereto (Filed With SEC on November 2, 2021)
- Second Amendment to Loan and Security Agreement, dated September 15, 2020, by and among Antares Pharma, Inc., Hercules Capital, Inc., and the several banks and other financial... (Filed With SEC on September 21, 2020)
- Form of Restricted Stock Unit Grant Agreement (Non-Employee Directors) (Filed With SEC on August 6, 2019)
- Form of Non-Qualified Stock Option Grant Agreement (Non-Employee Directors) (Filed With SEC on August 6, 2019)
- Form of Restricted Stock Unit Grant Agreement (Filed With SEC on August 6, 2019)
- Form of Non-Qualified Stock Option Grant Agreement (Filed With SEC on August 6, 2019)
- First Amendment to Loan and Security Agreement, dated June 26, 2019, by and among Antares Pharma, Inc., Hercules Capital, Inc., and the several banks and other financial... (Filed With SEC on June 27, 2019)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on June 7, 2017)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN RESTRICTED STOCK GRANT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN RESTRICTED STOCK UNIT GRANT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN NONQUALIFIED STOCK OPTION GRANT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. 2008 EQUITYCOMPENSATION PLAN RESTRICTED STOCK UNIT GRANT AGREEMENT (Filed With SEC on August 10, 2015)
- 20,000,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 6, 2015)
- 12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 4, 2012)
- 12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 13, 2011)
- COMMON STOCK PURCHASE WARRANT To Purchase [35% Coverage] Shares of Common Stock of ANTARES PHARMA, INC. (Filed With SEC on July 2, 2007)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 2, 2007)
- COMMON STOCK AND WARRANT PURCHASE AGREEMENT by and among Antares Pharma, Inc. and the parties named herein on Schedule 1, as Purchasers June 29, 2007 (Filed With SEC on July 2, 2007)
- CREDIT FACILITIES (Filed With SEC on March 2, 2007)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 2, 2007)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 20, 2006)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 20, 2006)
- COMMON STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 20, 2006)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 20, 2006)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 10, 2004)
- PURCHASE AGREEMENT (Filed With SEC on February 10, 2004)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 18, 2003)
- Warrant Agreement (Filed With SEC on September 18, 2003)
- FORM OF LIEN RELEASE AUTHORIZATION LETTER (Filed With SEC on September 15, 2003)
- SECURITIES EXCHANGE AGREEMENT (Filed With SEC on September 15, 2003)
